Home/Filings/4/0001209191-19-029597
4//SEC Filing

Walsh Jeffrey T. 4

Accession 0001209191-19-029597

CIK 0001293971other

Filed

May 13, 8:00 PM ET

Accepted

May 14, 4:08 PM ET

Size

13.0 KB

Accession

0001209191-19-029597

Insider Transaction Report

Form 4
Period: 2019-05-10
Walsh Jeffrey T.
Chief Operating Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2019-05-10$24.47/sh+1,500$36,70542,421 total
  • Sale

    Common Stock

    2019-05-10$131.10/sh200$26,22142,221 total
  • Sale

    Common Stock

    2019-05-10$132.38/sh1,100$145,61341,121 total
  • Sale

    Common Stock

    2019-05-10$133.08/sh200$26,61640,921 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2019-05-101,50011,521 total
    Exercise: $24.47Exp: 2024-03-03Common Stock (1,500 underlying)
Footnotes (5)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 2, 2018.
  • [F2]The range of prices for the transaction reported on this line was $130.61 to $131.60. The average weighted price was $131.105. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F3]The range of prices for the transaction reported on this line was $131.84 to $132.68. The average weighted price was $132.3755. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F4]The range of prices for the transaction reported on this line was $133.00 to $133.16. The average weighted price was $133.08. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F5]This option vested over a four-year period, at a rate of twenty-five percent (25%) on January 1, 2015 and in 36 equal monthly installments thereafter.

Issuer

bluebird bio, Inc.

CIK 0001293971

Entity typeother

Related Parties

1
  • filerCIK 0001578251

Filing Metadata

Form type
4
Filed
May 13, 8:00 PM ET
Accepted
May 14, 4:08 PM ET
Size
13.0 KB